Mylan (MYL) seeks approval for EpiPen with longer shelf life - Bloomberg

September 21, 2016 3:56 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mylan (NASDAQ: MYL) seeks approval for EpiPen with longer shelf life, according to Bloomberg.

The company says that the new shelf life could be as long as 24 months.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment